In the group of 4114 patients with breast cancer diagnosed at age above 50, CHEK2 mutations were present in 8 of 41 (19,5%) breast-thyroid cancer patients and in 324 of 4073 (8,0%) breast cancer patients (OR 2.81; P = 0.01). The gene discussed is CHEK2; the disease is breast cancer.